Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2019-04-01
2019-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this research study is to compare these two methods and determine if one technique gives better results, meaning less pain and fewer complications for patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Endoscopic Gastrostomy in Hands of ORL-HN Surgeon
NCT02937610
Feeding Tube in Cancer Patients
NCT02675673
The Effect of Semi-solid Feeding After Percutaneous Endoscopic Gastrostomy (PEG) on the Incidence of Aspiration Pneumonia and Postoperative Length of Stay
NCT02858596
PEG Application Experiences to Geriatric Patients
NCT05110235
A Retrospective Analysis of Percutaneous Endoscopic Gastrostomy Experiences
NCT05075616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Experiments with animal models have shown no evidence of gastric leakage following insertion of a 14 French tube, even when the tube is subsequently removed and the defect left unrepaired. Furthermore, several groups have had success without the use of gastropexy and some have described complications caused by performing this step such as peristomal infection, increased post-procedural pain, persistent leakage, and gastrocutaneous fistulas. Other large series of patients who underwent gastrostomy with gastropexy did not experience gastropexy-related complications, further complicating the matter. To date, the guidelines for transabdominal gastrostomy published by the Society of Interventional Radiology (SIR) and American Gastroenterological Association (AGA) acknowledge both techniques but have no official recommendation on the use of gastropexy reflecting the lack of clear evidence regarding advantage with or without its use.
The investigators hypothesize that the use of gastropexy for PRG does not significantly decrease complications.
The investigators also hypothesize that the use of gastropexy is associated with increased post procedural pain.
At the investigators' institution (University Health Network) PRG without gastropexy is regularly performed first-line for gastrostomy. There is a high volume of requests for PRG and thus establishing which method is superior will help to reduce the number of complications and revisions. In doing so, the investigators hope to be able to establish an optimal evidence-based protocol for PRG for future patients as well as improving patient safety and satisfaction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastropexy
Percutaneous radiologic guided insertion of G-tube. The skin over the epigastrium is prepared and draped in sterile fashion. Midazolam and fentanyl are administered for conscious sedation. Lidocaine for local analgesia. The stomach is insufflated with air after insertion of an OG or NG tube. Two T-fasteners are inserted into the stomach approximately 4cm apart. A needle is inserted into the stomach and an Amplatz wire is then inserted into the stomach. The tract is dilated with an 18Fr peel away sheath. A 14 Fr balloon retention gastrostomy tube is inserted. The balloon is inflated and bolster set as appropriate. The gastropexy/T-fastener sutures are cut after one week.
Gastropexy.
Two T-fasteners for G-tube insertion (gastropexy).
Non-Gastropexy
Percutaneous radiologic guided insertion of G-tube. The skin over the epigastrium is prepared and draped in sterile fashion. Midazolam and fentanyl are administered for conscious sedation. Lidocaine for local analgesia. The stomach is insufflated with air after insertion of an OG or NG tube. A needle is inserted into the stomach and an Amplatz wire is then inserted into the stomach. The tract is dilated with an 18Fr peel away sheath. A 14 Fr balloon retention gastrostomy tube is inserted. The balloon is inflated and bolster set as appropriate.
Non-Gastropexy
Insertion of G-tube in absence of T-fasteners.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gastropexy.
Two T-fasteners for G-tube insertion (gastropexy).
Non-Gastropexy
Insertion of G-tube in absence of T-fasteners.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dysphagia related to malignancy or surgery/radiation therapy
* Able to appropriately understand and complete English questionnaires either independently or with the assistance of a translator
Exclusion Criteria
* Unable or unwilling to complete the pre and post-procedure questionnaires
* Dysphagia related to neurological deficits
* Large volume of ascites
* Prior partial gastrectomy
* Long-term steroid use
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ganesan Annamalai
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto General Hospital - University Health Network
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ganesan Annamalai, MB, BCh, BAO, FRCSI, FRCR
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ganesan Annamalai, MB, BCh, BAO, FRCSI, FRCR
Role: primary
[email protected]
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-5102
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.